Skip to content
akaturk Academic measurement
Search

Article detail · 2014 · article

Oral manifestations of 17 patients affected with mucopolysaccharidosis type VI

YÖKSİS OpenAlex
Year2014
Citations42OpenAlex
Citations43Semantic Scholar · 4 influential
Percentile%77.5
FWCI1.181.00 = world average
Scopus (SJR)Q2
WoS (JCR)Q2

Data source split

  • YÖKSİSYÖKSİS article record
  • YÖKSİS venueJOURNAL OF INHERITED METABOLIC DISEASE
  • Catalog match (ISSN)Journal of Inherited Metabolic Disease
  • OpenAlexOpenAlex enrichment (abstract, citations, topics)
  • Semantic Scholarcitation count (not merged with OpenAlex)

Abstract

OpenAlex English

OBJECTIVE: To assess oral manifestations of 17 patients with mucopolysaccharidosis type VI (MPS VI) or Maroteaux-Lamy syndrome. METHODS: We performed comprehensive oral examinations in 17 patients with MPS VI. Panoramic radiographs was performed only in 14 patients. All patients were of Thai, Turkish, and Indian origins. Ten of 17 patients had enzyme replacement therapy (ERT) (Naglazyme). Most Turkish patients (10/11) were on ERT. The Thai and Indian patients have never had ERT. RESULTS: Oral and radiographic examinations showed that hypoplastic mandibular condyles (93.3 %), malposition of unerupted teeth (92.9 %), large dental follicles (92.3 %), anterior open bite (86.7 %), maxillary constriction (56.3 %), and taurodontism (53.8 %) were common among patients with MPS VI. Newly recognized oral findings found in our study included taurodontism, long tooth roots, abnormal frenum, missing teeth, supernumerary teeth, and microdontia. Two patients who started ERT prior to 3 years old did not develope anterior open bite and one of them had mildly affected mandibular condyles. CONCLUSION: Our study provides the most comprehensive study of oral manifestations in patients with MPS VI. Receiving ERT at very young ages may lessen craniofacial malformations including hypoplasic mandibular condyles and anterior open bite. Oral manifestations can be used as diagnostic features for MPS VI prior to assessing leukocyte ARSB activity or urinary excretion of dermatan sulfate.

Topics

Citations

OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.

42citationsOpenAlex · cited_by_count (cache / database)

12 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).

  1. 2018 Oral health status in patients with mucopolysaccharidosesCitations 28 · OpenAlex
  2. 2018 Oral health status in patients with mucopolysaccharidosesCitations 28 · OpenAlex
  3. 2018 Oral health status in patients with mucopolysaccharidosesCitations 28 · OpenAlex
  4. 2018 Oral health status in patients with mucopolysaccharidosesCitations 28 · OpenAlex
  5. 2018 Oral health status in patients with mucopolysaccharidosesCitations 28 · OpenAlex
  6. 2014 Clinical manifestations of 17 patients affected with mucopolysaccharidosis type VI and eight novel ARSB mutationsCitations 23 · OpenAlex
  7. 2014 Clinical manifestations of 17 patients affected with mucopolysaccharidosis type VI and eight novel ARSB mutationCitations 23 · OpenAlex
  8. 2023 Çukurova Popülasyonunda Gelişimsel Diş Anomalisi Görülme Sıklığı: Radyografik Bir ÇalışmaCitations 1 · OpenAlex
  9. 2023 Çukurova Popülasyonunda Gelişimsel Diş Anomalisi Görülme Sıklığı: Radyografik Bir ÇalışmaCitations 1 · OpenAlex
  10. 2025 Orofacial manifestations in mucopolysaccharidoses: a comprehensive clinical and radiographic evaluation of 35 pediatric casesCitations 0 · OpenAlex

Authors

8
  1. PIRANIT NIK KANTAPUTRA 1
  2. HÜLYA KAYSERİLİ KARABEY 2
  3. YELİZ GÜVEN İSTANBUL ÜNİVERSİTESİ 3
  4. WARISSARA KANTAPUTRA 4
  5. MEHMET CİHAN BALCI İSTANBUL ÜNİVERSİTESİ 5
  6. PRANOOT TANPAIBOON 6
  7. ANUSHA UTTARILI 7
  8. ASHWIN DALAL 8